Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. SEM
SEM logo

SEM Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
16.560
Open
16.545
VWAP
16.53
Vol
2.78M
Mkt Cap
2.05B
Low
16.505
Amount
45.92M
EV/EBITDA(TTM)
9.14
Total Shares
124.01M
EV
4.25B
EV/OCF(TTM)
10.96
P/S(TTM)
0.36
Select Medical Holdings Corporation operates critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics in the United States. Its segments include Critical Illness Recovery Hospital, Rehabilitation Hospital, and Outpatient Rehabilitation. Critical Illness Recovery Hospital segment consists of hospitals designed to serve the needs of patients recovering from critical illnesses, often with complex medical needs. It operates the majority of its critical illness recovery hospitals as a hospital within a hospital (an HIH). Rehabilitation Hospital segment serves patients that require intensive physical rehabilitation care. Outpatient Rehabilitation segment consists of clinics that provide physical, occupational, and speech rehabilitation services. It operates around 105 critical illness recovery hospitals in 29 states, 36 rehabilitation hospitals in 14 states, and 1,922 outpatient rehabilitation clinics in 39 states and the District of Columbia.
Show More

Events Timeline

(ET)
2026-05-21
09:10:00
Select Medical and Carilion Clinic Partner to Build 50-Bed Rehab Hospital
select
2026-04-30 (ET)
2026-04-30
16:50:00
Sees FY25 Adjusted EBITDA at $520M-$540M
select
2026-04-30
16:40:00
Company Reports Q1 Revenue of $1.421B
select
2026-03-04 (ET)
2026-03-04
06:30:00
Benchmark Downgrades Select Medical to Hold
select
2026-03-04
04:40:00
Deutsche Bank Downgrades Select Medical to Hold, Price Target $16.50
select
2026-03-03 (ET)
2026-03-03
05:30:00
RBC Capital Downgrades Select Medical to Sector Perform, Price Target Cut to $16.50
select
2026-03-02 (ET)
2026-03-02
18:50:00
Select Medical Enters Agreement for $16.50 Acquisition by Consortium
select

News

PRnewswire
8.5
05-19PRnewswire
Investor Rights Law Firm Investigates Multiple Companies
  • Insider Trading Investigation: Halper Sadeh LLC is investigating Select Medical Holdings Corporation's sale to a consortium led by its executives and directors for $16.50 per share in cash, which may infringe on shareholder rights.
  • UniFirst Acquisition Details: UniFirst Corporation is being sold to Cintas Corporation for $155.00 in cash and 0.7720 shares of Cintas stock per UniFirst share, potentially limiting superior competing offers.
  • Centessa Pharmaceuticals Deal: Centessa Pharmaceuticals plc is selling to Eli Lilly for $38.00 in cash per share plus a non-transferable contingent value right that could yield up to $9.00 upon achieving certain milestones, prompting shareholders to consider their rights.
  • Assertio Sale Dynamics: Assertio Holdings, Inc. is being sold to Garda Therapeutics for $18.00 per share in cash along with a contingent value right, with Halper Sadeh LLC potentially seeking increased consideration and additional disclosures for shareholders.
Yahoo Finance
6.5
05-17Yahoo Finance
Russell 2000 Index Potential Stock Analysis
  • Select Medical Risks: Select Medical (SEM), with a market cap of $2.04 billion, has seen declining admissions over the past two years, struggling to increase sales volumes and relying on price hikes, raising investor concerns about its future profitability.
  • Azenta's Poor Performance: Azenta (AZTA), valued at $808 million, has experienced a 1.6% annual sales decline over the past two years, with earnings per share contracting by 24.8% annually over five years, indicating its products have struggled to connect with the market, casting doubt on its long-term viability.
  • Talos Energy Investment Opportunity: Talos Energy (TALO), with a market cap of $2.56 billion, boasts a 16.9% annual revenue growth over the last eight years, indicating market share gains, while its 72.4% gross margin and strong free cash flow provide flexibility for growth investments or shareholder returns.
  • Market Environment Analysis: The high-risk, high-reward nature of the Russell 2000 index makes stock selection critical, and while there are potential quality stocks, investors must carefully assess the financial resilience and market adaptability of smaller companies.
PRnewswire
7.0
05-08PRnewswire
Investor Rights Law Firm Investigates Multiple Companies
  • Investigation Background: Halper Sadeh LLC is investigating companies like Select Medical Holdings, XOMA Royalty Corporation, Soleno Therapeutics, and KORE Group Holdings for potential violations of federal securities laws and fiduciary duties, which may impact shareholder rights.
  • Select Medical Transaction: Shareholders of Select Medical may face a sale to a consortium led by executives at $16.50 per share, with Halper Sadeh LLC potentially seeking increased consideration and additional disclosures to protect shareholder interests.
  • XOMA Royalty Transaction: XOMA Royalty Corporation shareholders are set to sell to Ligand Pharmaceuticals for $39.00 per share, and Halper Sadeh LLC may advocate for higher transaction prices and transparency to ensure shareholders' legal rights are upheld.
  • Soleno and KORE Transactions: Soleno Therapeutics shareholders will sell to Neurocrine Biosciences for $53.00 per share, while KORE Group Holdings shareholders will sell to Searchlight Capital Partners and Abry Partners for $9.25 per share, with Halper Sadeh LLC providing legal support to ensure these shareholders' rights are protected.
Fool
8.5
05-05Fool
Western Standard Exits Select Medical Holdings Position
  • Complete Exit: On May 5, 2026, Western Standard LLC fully exited its position in Select Medical Holdings by selling 2,064,021 shares, with an estimated transaction value of $32.30 million, reflecting a reassessment of the stock's future growth potential.
  • Impact of Price Fluctuations: Following this transaction, the value of Select Medical Holdings' stake decreased by $30.65 million, indicating a direct correlation between stock price changes and the liquidation, suggesting a cautious market outlook on the company’s future.
  • Background of Buyout: Select Medical announced a management-led buyout at $16.50 per share in March 2026, capping the stock's upside potential, which likely prompted Western Standard to exit before the stock price reached the buyout price, thus avoiding capital being tied up in a low-return investment.
  • Investor Insight: This event serves as a reminder for investors that after a fixed-price buyout announcement, the stock's upside potential is limited, leading many investors to sell and redeploy their capital to avoid idle funds while waiting for the deal to close.
PRnewswire
8.5
05-04PRnewswire
Investor Rights Law Firm Investigates Multiple Companies
  • Legal Investigation Launched: Halper Sadeh LLC is investigating Stellar Bancorp, Inc. (NYSE:STEL) for its sale to Prosperity Bancshares, Inc., involving 0.3803 shares of Prosperity common stock and $11.36 in cash per share, potentially infringing on shareholder rights.
  • Merger Transaction Review: The merger between Brink's Company (NYSE:BCO) and NCR Atleos Corporation will result in Brink's shareholders owning approximately 78% of the combined entity, prompting Halper Sadeh LLC to seek increased compensation for shareholders.
  • Cash Acquisition Scrutiny: Select Medical Holdings Corporation (NYSE:SEM) is being sold to a consortium led by its executives and directors for $16.50 in cash per share, with Halper Sadeh LLC assessing the implications of this transaction on shareholder interests.
  • Shareholder Rights Advocacy: NCR Atleos Corporation (NYSE:NATL) is being sold to Brink's Company for $30.00 in cash and 0.1574 shares of Brink's common stock per share, with Halper Sadeh LLC encouraging shareholders to understand their legal rights and options.
seekingalpha
9.5
05-01seekingalpha
Select Medical Q1 2026 Earnings Call Insights
  • Acquisition Agreement: Select Medical announced an acquisition agreement led by Robert Ortenzio, with shareholders set to receive $16.50 per share in cash, expected to close in mid-2026, which will provide the company with an additional $1 billion in loan capacity, enhancing financial flexibility.
  • Revenue Growth: The company reported a 5% year-over-year revenue increase, with inpatient rehabilitation revenue rising over 14% to approximately $351.9 million, indicating positive outcomes from its business expansion strategy amid strong market demand.
  • Financial Performance Analysis: Despite a 6.5% decline in adjusted EBITDA to $141.6 million, management maintained its full-year 2026 revenue guidance between $5.6 billion and $5.8 billion, reflecting confidence in future performance.
  • Market Risk Concerns: Management highlighted an increase in denial rates in the Medicare Advantage space, which is expected to negatively impact revenue in critical illness recovery hospitals by approximately $13 million to $14 million, reflecting regulatory and market challenges within the industry.
Wall Street analysts forecast SEM stock price to rise
4 Analyst Rating
Wall Street analysts forecast SEM stock price to rise
4 Buy
0 Hold
0 Sell
Strong Buy
Current: 0.000
sliders
Low
17.00
Averages
18.75
High
21.00
Current: 0.000
sliders
Low
17.00
Averages
18.75
High
21.00
Mizuho
Ann Hynes
Outperform -> Neutral
downgrade
$17
AI Analysis
2026-05-12
Reason
Mizuho
Ann Hynes
Price Target
$17
AI Analysis
2026-05-12
downgrade
Outperform -> Neutral
Reason
Mizuho analyst Ann Hynes downgraded Select Medical to Neutral from Outperform with a price target of $16.50, down from $17. The company is being taken private with the deal expected to close in mid-2026, pending shareholder approval, the analyst tells investors in a research note. Mizuho views the $16.50 in cash per share price as fair.
RBC Capital
Outperform
maintain
$20 -> $19
2026-02-23
Reason
RBC Capital
Price Target
$20 -> $19
2026-02-23
maintain
Outperform
Reason
RBC Capital lowered the firm's price target on Select Medical to $19 from $20 and keeps an Outperform rating on the shares. The stock declined about 7% on Friday after the company reported a Q4 adjusted EBITDA miss and softer-than-expected 2026 guidance, though the firm is encouraged that management does not expect a material headwind related to the high-cost outlier threshold within its CIRH segment in 2026, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for SEM
Unlock Now

Valuation Metrics

The current forward P/E ratio for Select Medical Holdings Corp (SEM.N) is 13.42, compared to its 5-year average forward P/E of 13.93. For a more detailed relative valuation and DCF analysis to assess Select Medical Holdings Corp's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
13.93
Current PE
13.42
Overvalued PE
16.43
Undervalued PE
11.43

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
10.41
Current EV/EBITDA
9.07
Overvalued EV/EBITDA
11.40
Undervalued EV/EBITDA
9.42

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
0.51
Current PS
0.34
Overvalued PS
0.66
Undervalued PS
0.36

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

potential swing trade possibilities?
Intellectia · 22 candidates
Region: USPrice: $5.00 - $150.00Rsi Category: moderateList Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceAboveMA20Support Resistance Relationship: PriceAroundSupportMonthly Average Dollar Volume: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
HOLX logo
HOLX
Hologic Inc
16.97B
VNOM logo
VNOM
Viper Energy Inc
16.56B
JHG logo
JHG
Janus Henderson Group PLC
7.93B
AL logo
AL
Air Lease Corp
7.28B
SEE logo
SEE
Sealed Air Corp
6.20B
PAGP logo
PAGP
Plains GP Holdings LP
5.55B
what stocks I would profit fast
Intellectia · 29 candidates
Region: USPrice: $2.00 - $50.00Relative Vol: >= 1.50List Exchange: XNYS, XNAS, XASEWeek Price Change Pct: $5.00 - $80.00One Week Rise Prob: >= 60Monthly Average Dollar Volume: >= 500,000
Ticker
Name
Market Cap$
top bottom
DV logo
DV
DoubleVerify Holdings Inc
1.65B
INDO logo
INDO
Indonesia Energy Corp Ltd
78.68M
SEM logo
SEM
Select Medical Holdings Corp
2.02B
USGO logo
USGO
US GoldMining Inc
179.25M
GTE logo
GTE
Gran Tierra Energy Inc
232.25M
OUST logo
OUST
Ouster Inc
1.36B

Whales Holding SEM

E
Eversept Partners, L.P.
Holding
SEM
-5.73%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Select Medical Holdings Corp (SEM) stock price today?

The current price of SEM is 16.52 USD — it has decreased -0.12

What is Select Medical Holdings Corp (SEM)'s business?

Select Medical Holdings Corporation operates critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics in the United States. Its segments include Critical Illness Recovery Hospital, Rehabilitation Hospital, and Outpatient Rehabilitation. Critical Illness Recovery Hospital segment consists of hospitals designed to serve the needs of patients recovering from critical illnesses, often with complex medical needs. It operates the majority of its critical illness recovery hospitals as a hospital within a hospital (an HIH). Rehabilitation Hospital segment serves patients that require intensive physical rehabilitation care. Outpatient Rehabilitation segment consists of clinics that provide physical, occupational, and speech rehabilitation services. It operates around 105 critical illness recovery hospitals in 29 states, 36 rehabilitation hospitals in 14 states, and 1,922 outpatient rehabilitation clinics in 39 states and the District of Columbia.

What is the price predicton of SEM Stock?

Wall Street analysts forecast SEM stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SEM is18.75 USD with a low forecast of 17.00 USD and a high forecast of 21.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Select Medical Holdings Corp (SEM)'s revenue for the last quarter?

Select Medical Holdings Corp revenue for the last quarter amounts to 1.42B USD, increased 5.05

What is Select Medical Holdings Corp (SEM)'s earnings per share (EPS) for the last quarter?

Select Medical Holdings Corp. EPS for the last quarter amounts to 0.35 USD, decreased -20.45

How many employees does Select Medical Holdings Corp (SEM). have?

Select Medical Holdings Corp (SEM) has 30800 emplpoyees as of May 24 2026.

What is Select Medical Holdings Corp (SEM) market cap?

Today SEM has the market capitalization of 2.05B USD.